Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2024 Earnings Call Transcript February 18, 2025 Halozyme Therapeutics, Inc. beats earnings expectations. Reported EPS is $1.26, expectations were $1.17.
The application deadline for general scholarships is March 1, 2026. The deadline for nursing, allied health, and trade school ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback